ASHPOfficial

Educators have noticed a growing trend of learners not exhibiting behaviors that will help them in the professional workforce, while learners might now understand the expectations educators will have of them. This podcast will shed the led the light on how professionalism is defined by different groups and how we can bridge the chasm that seems to exist.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership episode, Hesham Mourad, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with SOPIT member and Distinguished Service Awardee for 2024, Julie Pawola, to discuss her service within the section and the role ASHP has played in her development as a pharmacy practice leader. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Suzanne Harris and Dr. Charles Caley discuss the AJHP Practice Research Report, “Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide an overview of how data analytics-related careers for pharmacy professionals will evolve as organizational needs and technology change. Panelists on this podcast currently work in data analytics-related roles and will discuss automation, predictive analytics, real-world evidence and artificial intelligence.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Mariah Hollabaugh, director of pharmacy at Citizens Memorial Hospital, Hayle Gillespie, medication access specialist at Citizens Memorial Hospital, and Jodie Gregg, an advocate and patient. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the Food and Drug Administration and National Institutes of Health Biomarker Working Group updates to the original 2018 BEST Resource in 2021, including the understanding and classification of biomarkers like BRCA1 and BRCA 2. This presentation highlights how these changes affect cancer risk diagnostics and provides a resource for evidence-based application of specific genetic testing in the pharmacist’s clinical practice. CE for this episode expires two years after its original publication date. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode provides an overview of notable changes to state laws that have occurred thus far in 2025 and insight into key issues currently being considered in state legislatures, including efforts to broaden pharmacist scope of practice, achieve pharmacist provider status and regulate pharmacy benefit managers. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us as we explore providing data for specialty medication access.  Hear from experienced individuals who detail their daily challenges, as well as considerations provided that may be helpful in your data for access journey.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode dives into the Medicare Prescription Payment Plan (M3P), launched in 2025, and its impact on specialty pharmacies across the U.S. The episode discusses how this policy is changing patient access, pharmacy reimbursement, and operational strategies, while also highlighting the challenges and opportunities specialty pharmacies face in adapting to these shifts. Whether you're a healthcare professional, pharmacist, or policy expert, this episode unpacks everything you need to know about M3P and its role in shaping the future of specialty pharmacy.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership episode, David Chen sits down with the Section of Pharmacy Practice Leaders’ 2024 Awardee Della Bahmandar to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.